The Global Lung Cancer Surgery Market Size accounted for USD 5.7 Billion in 2021 and is projected to achieve a market size of USD 8.3 Billion by 2030 rising at a CAGR of 4.3% from 2022 to 2030. Cancer is a disease caused due to abnormal cell division without control and that can invade nearby tissues. Cancerous cells can also spread to other organs of the body through the blood and lymph systems. Cancer is the second major leading cause of death after cardiovascular disorders. Lung cancer is a Product of cancer that starts from the lung and may spread to other organs. Lung cancer contributes a major reason of all cancer deaths globally.
Lung Cancer Surgery Market Report Statistics
- Global lung cancer surgery market revenue is estimated to reach USD 8.3 Billion by 2030 with a CAGR of 4.3% from 2022 to 2030
- North America lung cancer surgery market share accounted for over 36% shares in 2021
- According to the American Cancer Society’s estimates, there will be 236,740 new cases of lung cancer in the U.S.
- Asia-Pacific lung cancer surgery market growth will record fastest CAGR from 2022 to 2030
- Based on procedure, thoracotomy gathered over 60% of the overall market share in 2021
- Increasing incidences of lung cancer will fuel the global lung cancer surgery market value
- Growing technological advancement in lung cancer treatment is a popular lung cancer surgery market trend that is fueling the industry demand
People who smoke and consume tobacco products have the greatest risk of lung cancer. The risk of lung cancer increases with the time period and number of cigarettes smoked or tobacco products consumed. The treatment for lung cancer depends on the Product and stage of cancer. Mainly there are 2 types of lung cancer such as small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). Several treatments are available for the treatment of lung cancer viz. chemotherapy, immunotherapy, laser therapy, radiation therapy, targeted therapy, and surgery. Surgery is the final option for the treatment of lung cancer and it involves surgically removal of cancer tissues from the lung. The approaches for surgeries are large incision in the chest wall known as thoracotomy or via video-assisted thoracoscopy (VATS), a procedure in which a scope like device is inserted through small incisions in the chest wall and through which a tumour is removed. Three major types of surgery are done to treat lung cancer and these depend on the degree of infection, size and location of the tumour. These are wedge resection (segmental resection), lobectomy, pneumonectomy. New surgical approaches to robotic surgery and technological developments such as minimally invasive surgical procedures are new trends in the lung cancer market. According to the world health organization, the consumption of tobacco products is the major cause of lung cancer and tobacco contributes around 80% of all lung cancers. As per the WHO report lung cancer cases in developing economies is expected to reach 2,530,820 by 2025.
Global Lung Cancer Surgery Market Dynamics
Market Drivers
- Growing prevalence of lung cancer
- Increasing trend of smoking tobacco
- Rising base of elderly population
- Surging number of diagnostic centers
Market Restraints
- High cost of lung cancer treatment
- Shortage of skilled oncologists
Market Opportunities
- Government funding for early detection of cancer
- Rising technological advancements in lung cancer surgeries
Lung Cancer Surgery Market Report Coverage
Market |
Lung Cancer Surgery Market |
Lung Cancer Surgery Market Size 2021 |
USD 5.7 Billion |
Lung Cancer Surgery Market Forecast 2030 |
USD 8.3 Billion |
Lung Cancer Surgery Market CAGR During 2022 - 2030 |
4.3 % |
Lung Cancer Surgery Market Analysis Period |
2018 - 2030 |
Lung Cancer Surgery Market Base Year |
2021 |
Lung Cancer Surgery Market Forecast Data |
2022 - 2030 |
Segments Covered |
By Product, By Procedure, By End-User, And By Geography
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa |
Key Companies Profiled |
Ethicon LLC, Intuitive Surgical, Inc., Karl Storz GmbH & Co. KG, Olympus Corporation, Accuray Inc., AngioDynamics Inc., Teleflex Incorporated, Ackermann Instrumente GmbH, Medtronic Plc., Siemens Healthcare, Surgical Holdings, Wexler Surgical Inc, Covidien PLC, Scanlan International Inc. |
Report Coverage
|
Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis |
Covid-19 Impact on Global Lung Cancer Surgery Market
According to an article published by Dana Farber Cancer Institute in 2020, there was a 46% reduction in the surgery of the six most prevalent cancer types including lung cancer because of the Covid-19 pandemic. The lung cancer surgery market is experiencing tremendous challenges during this pandemic to diagnose the virus-related lung symptom and cancer related symptoms, along with higher risk of infection in the hospital setting. Resources requirement has been doubled in diagnosis and treatment of lung cancer due to the covid-19 pandemic, these results in increased expenditure towards healthcare facilities. The pandemic also affects the market indirectly since raised disruptions in demand, manufacturing and supply chain.
Lung Cancer Market Dynamics
The increasing prevalence, incidence of lung cancer and the increasing adoption of surgical procedures for lung cancer treatment are the major driving factors for market growth. Sedentary lifestyle, rising air pollution and consumption of tobacco products are the factors responsible for the growth of the market. Rising government support and funding towards R&D would swift the growth of the market. Technological advancements in treatment of lung cancer surgery and arrival of new minimally invasive surgeries are some of the factors fuelling growth of the market. Technological development in endoscopic visual devices and various surgical devices improve the ease of the surgery and have resulted in high success rates during difficult conditions. However, the hefty costs for the treatment of lung cancer and limited medical infrastructure despite high patient pool are some of the factors restraining the market growth.
Lung Cancer Surgery Market Segmentation
The worldwide lung cancer surgery market is split based on product, procedure, end-user, and geography. The product segment is further sub-segmented as surgical instruments and monitoring & visualization system. The procedure segment is further bifurcated as thoracotomy and minimally invasive surgeries. The end-user segment is diversified into hospitals/clinics, ambulatory surgical centers and research laboratories. The surgical instruments segment is expected to hold the largest lung cancer surgery market share owing to the rising number of patients requiring lung cancer surgeries.
Lung Cancer Surgery Market By Product
- Surgical Instruments
- Powered Surgical Instruments
- Hand Instruments
- Monitoring And Visualization System
Lung Cancer Surgery Market By Procedure
- Thoracotomy
- Lobectomy
- Sleeve Resection
- Segmentectomy
- Pneumonectomy
- Minimally Invasive Surgeries
Lung Cancer Surgery Market By End-User
- Hospitals/Clinics
- Ambulatory Surgical Centers
- Research Laboratories
Lung Cancer Surgery Market Regional Outlook
North America
Europe
- U.K.
- Germany
- France
- Spain
- Rest of Europe
Asia-Pacific
- India
- Japan
- China
- Australia
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Mexico
- Rest of Latin America
The Middle East & Africa
- South Africa
- GCC Countries
- Rest of the Middle East & Africa (ME&A)
Lung Cancer Surgery Market Regional Analysis
North America is expected to dominate the market due higher prevalence rate of lung cancer coupled with advanced healthcare infrastructure supporting technologically advanced surgeries. After North America, Europe also is anticipated to have a considerable growth in the market as owing to growth in lung ailments. The Asian market is expected to witness the highest growth during the forecast period, primarily due to the presence of rising patient pool, increasing incidence & prevalence of lung cancer, rapid developments in healthcare sector and rising trend of smoking tobacco.
Lung Cancer Surgery Market Players
The prominent players of the global lung cancer surgery market involve Ethicon LLC, Intuitive Surgical, Inc., Karl Storz GmbH & Co. KG, Olympus Corporation, Accuray Inc., AngioDynamics Inc., Teleflex Incorporated, Ackermann Instrumente GmbH, Medtronic Plc., Siemens Healthcare, Surgical Holdings, Wexler Surgical Inc, Covidien PLC, Scanlan International Inc.
CHAPTER 1. Industry Overview of Lung Cancer Surgery Market
1.1. Definition and Scope
1.1.1. Definition of Lung Cancer Surgery
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Lung Cancer Surgery Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Lung Cancer Surgery Market By Product
1.2.3. Lung Cancer Surgery Market By Procedure
1.2.4. Lung Cancer Surgery Market By End-User
1.2.5. Lung Cancer Surgery Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Lung Cancer Surgery Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Lung Cancer Surgery Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Regulatory Compliance
3.9. Competitive Landscape, 2021
3.9.1. Player Positioning Analysis
3.9.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Lung Cancer Surgery Market By Product
4.1. Introduction
4.2. Lung Cancer Surgery Revenue By Product
4.2.1. Lung Cancer Surgery Revenue (USD Billion) and Forecast, By Product, 2018-2030
4.2.2. Surgical Instruments
4.2.2.1. Surgical Instruments Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.2. Powered Surgical Instruments
4.2.2.2.1. Powered Surgical Instruments Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.2.3. Hand Instruments
4.2.2.3.1. Hand Instruments Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
4.2.3. Monitoring And Visualization System
4.2.3.1. Monitoring And Visualization System Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 5. Lung Cancer Surgery Market By Procedure
5.1. Introduction
5.2. Lung Cancer Surgery Revenue By Procedure
5.2.1. Lung Cancer Surgery Revenue (USD Billion) and Forecast, By Procedure, 2018-2030
5.2.2. Thoracotomy
5.2.2.1. Thoracotomy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.2.2. Lobectomy
5.2.2.2.1. Lobectomy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.2.3. Sleeve Resection
5.2.2.3.1. Sleeve Resection Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.2.4. Segmentectomy
5.2.2.4.1. Segmentectomy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.2.5. Pneumonectomy
5.2.2.5.1. Pneumonectomy Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
5.2.3. Minimally Invasive Surgeries
5.2.3.1. Minimally Invasive Surgeries Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 6. Lung Cancer Surgery Market By End-User
6.1. Introduction
6.2. Lung Cancer Surgery Revenue By End-User
6.2.1. Lung Cancer Surgery Revenue (USD Billion) and Forecast, By End-User, 2018-2030
6.2.2. Hospitals/Clinics
6.2.2.1. Hospitals/Clinics Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.3. Ambulatory Surgical Centers
6.2.3.1. Ambulatory Surgical Centers Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
6.2.4. Research Laboratories
6.2.4.1. Research Laboratories Market Revenue (USD Billion) and Growth Rate (%), 2018-2030
CHAPTER 7. North America Lung Cancer Surgery Market By Country
7.1. North America Lung Cancer Surgery Market Overview
7.2. U.S.
7.2.1. U.S. Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
7.2.2. U.S. Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
7.2.3. U.S. Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
7.3. Canada
7.3.1. Canada Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
7.3.2. Canada Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
7.3.3. Canada Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
7.4. North America PEST Analysis
CHAPTER 8. Europe Lung Cancer Surgery Market By Country
8.1. Europe Lung Cancer Surgery Market Overview
8.2. U.K.
8.2.1. U.K. Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
8.2.2. U.K. Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
8.2.3. U.K. Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.3. Germany
8.3.1. Germany Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
8.3.2. Germany Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
8.3.3. Germany Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.4. France
8.4.1. France Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
8.4.2. France Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
8.4.3. France Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.5. Spain
8.5.1. Spain Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
8.5.2. Spain Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
8.5.3. Spain Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.6. Rest of Europe
8.6.1. Rest of Europe Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
8.6.2. Rest of Europe Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
8.6.3. Rest of Europe Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
8.7. Europe PEST Analysis
CHAPTER 9. Asia Pacific Lung Cancer Surgery Market By Country
9.1. Asia Pacific Lung Cancer Surgery Market Overview
9.2. China
9.2.1. China Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
9.2.2. China Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
9.2.3. China Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.3. Japan
9.3.1. Japan Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
9.3.2. Japan Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
9.3.3. Japan Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.4. India
9.4.1. India Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
9.4.2. India Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
9.4.3. India Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.5. Australia
9.5.1. Australia Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
9.5.2. Australia Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
9.5.3. Australia Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.6. South Korea
9.6.1. South Korea Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
9.6.2. South Korea Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
9.6.3. South Korea Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.7. Rest of Asia-Pacific
9.7.1. Rest of Asia-Pacific Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
9.7.2. Rest of Asia-Pacific Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
9.7.3. Rest of Asia-Pacific Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
9.8. Asia Pacific PEST Analysis
CHAPTER 10. Latin America Lung Cancer Surgery Market By Country
10.1. Latin America Lung Cancer Surgery Market Overview
10.2. Brazil
10.2.1. Brazil Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
10.2.2. Brazil Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
10.2.3. Brazil Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.3. Mexico
10.3.1. Mexico Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
10.3.2. Mexico Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
10.3.3. Mexico Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.4. Rest of Latin America
10.4.1. Rest of Latin America Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
10.4.2. Rest of Latin America Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
10.4.3. Rest of Latin America Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
10.5. Latin America PEST Analysis
CHAPTER 11. Middle East & Africa Lung Cancer Surgery Market By Country
11.1. Middle East & Africa Lung Cancer Surgery Market Overview
11.2. GCC
11.2.1. GCC Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
11.2.2. GCC Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
11.2.3. GCC Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.3. South Africa
11.3.1. South Africa Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
11.3.2. South Africa Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
11.3.3. South Africa Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.4. Rest of Middle East & Africa
11.4.1. Rest of Middle East & Africa Lung Cancer Surgery Revenue (USD Billion) and Forecast By Product, 2018-2030
11.4.2. Rest of Middle East & Africa Lung Cancer Surgery Revenue (USD Billion) and Forecast By Procedure, 2018-2030
11.4.3. Rest of Middle East & Africa Lung Cancer Surgery Revenue (USD Billion) and Forecast By End-User, 2018-2030
11.5. Middle East & Africa PEST Analysis
CHAPTER 12. Player Analysis Of Lung Cancer Surgery Market
12.1. Lung Cancer Surgery Market Company Share Analysis
12.2. Competition Matrix
12.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
12.2.2. New Product Launches and Product Enhancements
12.2.3. Mergers And Acquisition In Global Lung Cancer Surgery Market
12.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 13. Company Profile
13.1. Ethicon LLC
13.1.1. Company Snapshot
13.1.2. Business Overview
13.1.3. Financial Overview
13.1.3.1. Revenue (USD Billion), 2021
13.1.3.2. Ethicon LLC 2021 Lung Cancer Surgery Business Regional Distribution
13.1.4. Product /Service and Specification
13.1.5. Recent Developments & Business Strategy
13.2. Intuitive Surgical, Inc.
13.3. Karl Storz GmbH & Co. KG
13.4. Olympus Corporation
13.5. Accuray Inc.
13.6. AngioDynamics Inc.
13.7. Teleflex Incorporated
13.8. Ackermann Instrumente GmbH
13.9. Medtronic Plc.
13.10. Siemens Healthcare
13.11. Surgical Holdings
13.12. Wexler Surgical Inc
13.13. Covidien PLC
13.14. Scanlan International Inc.